Germany Artificial Intelligence In Cancer Diagnostics Market Size & Outlook
- Healthcare IT
- AI in Healthcare
- Artificial Intelligence In Cancer Diagnostics Market Outlook
- AI in Healthcare
Global Market
Related Markets
Ask Prism AI about the artificial intelligence in cancer diagnostics market
Get cited answers from GVR research on market growth, segments, regulations and forecasts.
- Source-linked answers
- Market-specific context
- Traceable figures
Germany artificial intelligence in cancer diagnostics market highlights
- The Germany artificial intelligence in cancer diagnostics market generated a revenue of USD 11.1 million in 2025 and is expected to reach USD 64.7 million by 2033.
- The Germany market is expected to grow at a CAGR of 22.7% from 2026 to 2033.
- In terms of segment, software was the largest revenue generating component in 2025.
- Services is the most lucrative component segment registering the fastest growth during the forecast period.
Artificial intelligence in cancer diagnostics market data book summary
| Market revenue in 2025 | USD 11.1 million |
| Market revenue in 2033 | USD 64.7 million |
| Growth rate | 22.7% (CAGR from 2026 to 2033) |
| Largest segment | Software |
| Fastest growing segment | Services |
| Historical data | 2021 - 2024 |
| Base year | 2025 |
| Forecast period | 2026 - 2033 |
| Quantitative units | Revenue in USD million |
| Market segmentation | Software, Hardware, Services |
| Key market players worldwide | Microsoft Corp, Roche Holding AG, Quest Diagnostics Inc, Medial EarlySign, CancerCenter.AI, Therapixel, Tempus, Kheiron, SkinVision |
Other key industry trends
- In terms of revenue, Germany accounted for 3.3% of the global artificial intelligence in cancer diagnostics market in 2025.
- Country-wise, U.S. is expected to lead the global market in terms of revenue in 2033.
- In Europe, UK artificial intelligence in cancer diagnostics market is projected to lead the regional market in terms of revenue in 2033.
- Russia is the fastest growing regional market in Europe and is projected to reach USD 17.8 million by 2033.
Germany AI in cancer diagnostics market is growing at a significant pace owing to increasing adoption of AI by health insurers and in medical imaging for diagnosis of cancer. Several investments in the field of AI in healthcare have positively influenced market growth.
For instance, investments by venture capital firm High-Tech Gründerfonds, which has made around 489 investments worth USD 942 billion in high-tech startups in areas such as robotics & virtual reality, have fueled growth of the market. According to PwC Germany, Sherlock in Health has discovered that the usage of AI in the early detection of diseases can save around EUR 70 billion (USD 74.5 billion) in healthcare costs in Europe in the coming decade.
Merantix, a Germany-based AI research lab, builds machine learning companies in several fields, including healthcare. The company has developed an AI algorithm that analyzes mammogram X-rays and detects abnormalities & signs of cancer with reliable accuracy.
No credit card required*
Publish Date: Jun 22, 2026
Customize the Report
20% free customization
- Include
- Countries, segments, points
- Tailor
- To your product definition
- Extend
- Deeper competitor detail
- Or
- A fully bespoke study
- Turnaround
- 5–10 working days
Horizon in a snapshot
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
Artificial Intelligence In Cancer Diagnostics Market Scope
Artificial Intelligence In Cancer Diagnostics Market Companies
| Name | Profile | # Employees | HQ | Website |
|---|---|---|---|---|
| Microsoft Corp | View profile | 221,000 | One Microsoft Way, Redmond, WA, United States, 98052-6399 | www.microsoft.com |
| Roche Holding AG | View profile | 103,605 | Grenzacherstrasse 124, Basel, Switzerland, 4070 | www.roche.com |
| Quest Diagnostics Inc | View profile | 48,000 | 500 Plaza Drive, Secaucus, NJ, United States, 07094 | www.questdiagnostics.com |
| Medial EarlySign | View profile | 11-50 | Hod Hasharon, HaMerkaz, Israel, Asia | earlysign.com/ |
| CancerCenter.AI | View profile | 11-50 | Wroclaw, Dolnoslaskie, Poland, Europe | cancercenter.ai |
| Therapixel | View profile | 11-50 | Nice, Provence-Alpes-Cote d'Azur, France, Europe | www.therapixel.com/ |
| Tempus | View profile | 501-1000 | Chicago, Illinois, United States, North America | www.tempus.com |
| Kheiron | View profile | 11-50 | London, England, United Kingdom, Europe | www.kheironmed.com/ |
| SkinVision | View profile | 11-50 | Amsterdam, Noord-Holland, The Netherlands, Europe | skinvision.com |
Germany Artificial Intelligence In Cancer Diagnostics Market Outlook
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to Artificial Intelligence In Cancer Diagnostics Market Outlook will help companies and investors design strategic landscapes.
Software was the largest segment with a revenue share of 68.47% in 2025.
Horizon Databook has segmented the Germany artificial intelligence in cancer diagnostics market based on software, hardware, services covering the revenue growth of each sub-segment from 2021 to 2033.
Germany AI in cancer diagnostics market is growing at a significant pace owing to increasing adoption of AI by health insurers and in medical imaging for diagnosis of cancer. Several investments in the field of AI in healthcare have positively influenced market growth.
For instance, investments by venture capital firm High-Tech Gründerfonds, which has made around 489 investments worth USD 942 billion in high-tech startups in areas such as robotics & virtual reality, have fueled growth of the market. According to PwC Germany, Sherlock in Health has discovered that the usage of AI in the early detection of diseases can save around EUR 70 billion (USD 74.5 billion) in healthcare costs in Europe in the coming decade.
Merantix, a Germany-based AI research lab, builds machine learning companies in several fields, including healthcare. The company has developed an AI algorithm that analyzes mammogram X-rays and detects abnormalities & signs of cancer with reliable accuracy.
- Germany Artificial Intelligence In Cancer Diagnostics Market Component Outlook (Revenue, USD Million , 2021-2033)
- Software
- Hardware
- Services
- Germany Artificial Intelligence In Cancer Diagnostics Market Cancer Type Outlook (Revenue, USD Million , 2021-2033)
- Colorectal Cancer
- Lung Cancer
- Prostate Cancer
- Others
- Breast Cancer
- Brain Tumor
- Germany Artificial Intelligence In Cancer Diagnostics Market End Use Outlook (Revenue, USD Million , 2021-2033)
- Hospital
- Surgical Centers and Medical Institutes
- Others
Reasons to subscribe to Artificial Intelligence In Cancer Diagnostics Market Outlook databook
- Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
- Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
- Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
- Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
- Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.
Target buyers of Artificial Intelligence In Cancer Diagnostics Market Outlook databook
- Our clientele includes a mix of Artificial Intelligence In Cancer Diagnostics Market Outlook companies, investment firms, advisory firms & academic institutions.
- 30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
- Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
- The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.
Horizon Databook provides a detailed overview of country-level data and insights on the Germany Artificial Intelligence In Cancer Diagnostics Market Outlook, including forecasts for subscribers. This country databook contains high-level insights into Germany Artificial Intelligence In Cancer Diagnostics Market Outlook from 2021 to 2033, including revenue numbers, major trends, and company profiles.
Germany Artificial Intelligence In Cancer Diagnostics Market, 2021-2033 (US$M)
Germany artificial intelligence in cancer diagnostics market statistics, by component, 2021-2033 (US$M)
